I partially disagree, not from the investment point of view, but probably from the scientific point of view (I am not a scientist by the way) Many biotech companies operate in the same way until they come up with a big and innovative product that change the world. I think (hope) ACTC will do that sooner rather than later, but I can wait. The only thing that will cripple everyone out is bankruptcy, and I hope that doesn't happen.
News 
Market Data 
Discover 
